Market Tracker

04/21 5:16pm ET

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

4.91
Delayed Data
As of Apr 21
 0.00 / 0.00%
Today’s Change
4.39
Today|||52-Week Range
9.29
-14.90%
Year-to-Date

Today’s Trading

Previous close4.91
Today’s open4.56
Day’s range4.41 - 4.91
Volume6,476,092
Average volume (3 months)2,904,557
Market cap$969.8M
Dividend yield--
Data as of 4:00pm ET, 04/21/2017

Growth & Valuation

Earnings growth (last year)+6.12%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)-3.90%
P/E ratioNM
Price/Sales58.45
Price/Book7.58

Competitors

 Today’s
change
Today’s
% change
AIMTAimmune Therapeutics...-0.58-2.95%
IPXLImpax Laboratories I...+0.15+1.12%
FWPForward Pharma A/S-0.31-1.56%
SGYPSynergy Pharmaceutic...0.000.00%
Data as of 3:59pm ET, 04/21/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$19.4M
Annual profit (last year)-$89.9M
Net profit margin-464.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts